Axa’s Rover Group, Inc. Class A Common Stock ROVR Stock Holding History

Axa’s Portfolio ROVR Stock Details ROVR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-163,400	Closed	-$1.02M	–	1153
2023 Q3	$1.02M	Hold	163,400	–	–	﹤0.01%	834
2023 Q2	$802K	Buy	+163,400	New	+$747K	﹤0.01%	878

Other funds holding ROVR

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

FGN

Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

Axa's ROVR Position: Q4 2023 in Review

Axa sold out of Rover Group, Inc. Class A Common Stock (ROVR) in Q4 2023, closing a stake of 163,400 shares — an estimated $1.02M sold.

Axa first reported a position in ROVR in Q2 2023 and held it in 2 quarters. The position peaked at $1.02M in Q3 2023. 153 funds tracked by Wall St. Rank hold ROVR as of Q4 2023.

Axa reported no remaining Rover Group, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
Axa sold 163,400 Rover Group, Inc. Class A Common Stock shares in Q4 2023, an estimated $1.02M.
Axa first reported a position in Rover Group, Inc. Class A Common Stock in Q2 2023 and held it in 2 quarters.
Axa's Rover Group, Inc. Class A Common Stock position peaked at $1.02M in Q3 2023.
153 funds tracked by Wall St. Rank held Rover Group, Inc. Class A Common Stock as of Q4 2023.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.